Key result
Ranolazine (5-10 µM) completely suppressed late phase 3 EAD- and DAD-induced triggered activity in 100% (8 of 8) of canine coronary sinus preparations.
Why the study?
Does ranolazine suppress autonomic-induced triggered activity in canine coronary sinus preparations?
Does ranolazine suppress autonomic-induced triggered activity in canine coronary sinus preparations?
Ranolazine effectively suppresses autonomic-induced triggered activity in canine coronary sinus preparations, suggesting a potential mechanism for its antiarrhythmic effects in atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Provides mechanistic support for ranolazine in AF models; leaves open clinical translation pending human studies.
Introduction Extrasystoles arising from the muscular sleeves associated with the pulmonary veins (PV), superior vena cava (SVC), and coronary sinus (CS) are known to precipitate atrial fibrillation (AF). The late sodium channel current ( I Na ) inhibitor ranolazine has been reported to exert antiarrhythmic effects in canine PV and SVC sleeves by suppressing late phase 3 early and delayed after depolarization (EAD and DAD)‐induced triggered activity induced by parasympathetic and/or sympathetic stimulation. The current study was designed to extend our existing knowledge of the electrophysiological and pharmacologic properties of canine CS preparations and assess their response to inhibition of late I Na following autonomic stimulation. Methods Transmembrane action potentials were recorded from canine superfused CS using standard microelectrode techniques. Acetylcholine (ACh, 1 µM), isoproterenol (Iso, 1 µM), high calcium ([Ca 2+ ] o = 5.4 mM), or a combination were used to induce EADs, DADs, and triggered activity. Results Action potentials (AP) recorded from the CS displayed short and long AP durations (APD), with and without phase 4 depolarization ( n = 19). Iso induced DAD‐mediated triggered activity. The combination of sympathetic and parasympathetic agonists resulted in late phase 3 EAD‐induced triggered activity in all CS preparations. Ranolazine (5‐10 µM) suppressed late phase 3 EAD‐ and DAD‐induced triggered activity in 8 of 8 preparations. Subthreshold stimulation induced a prominent hyperpolarization that could be suppressed by atropine. Conclusions Our results suggest the important role of parasympathetic innervation in the activity of the CS. Autonomic influences promote DAD‐ and late phase‐3‐EAD‐mediated triggered activity in canine CS, thus generating extrasystolic activity capable of initiating atrial arrhythmias. Ranolazine effectively suppresses these triggers.
No takes yet. Share an insight, caveat, or question.
Sicouri et al. (2018) studied Atrial fibrillation triggers (n=19). Ranolazine was evaluated on Suppression of late phase 3 EAD- and DAD-induced triggered activity. Ranolazine (5-10 µM) completely suppressed late phase 3 EAD- and DAD-induced triggered activity in 100% (8 of 8) of canine coronary sinus preparations.
Synapse has enriched 10 related papers. Consider them for comparative context: